跳至主要内容
临床试验/NCT05889637
NCT05889637已完成不适用

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1(GLP-1) Receptor Agonists

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2023年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
132
试验地点
1
主要终点
Number of subjects that are at risk for aspiration

研究概览

简要总结

The purpose of this study is to determine the type of gastric content and quantify the volume of liquid gastric contents using ultrasonography in patients on GLP-1 agonists that have presented for elective surgery and to determine if risk factors are associated with a higher gastric volume in patients on GLP-1 receptor agonists.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients taking GLP-1receptor agonists (N=62)
  • Patients not taking GLP-1 receptor agonists (N=62)

排除标准

  • Previous gastric resection or bypass
  • Gastric band in situ
  • Previous fundoplication
  • Large hiatal hernia
  • Pregnant patients
  • Recent trauma
  • Inability to turn to the right lateral decubitus position

结局指标

主要结局

Number of subjects that are at risk for aspiration

时间窗: end of ultrasound

Risk for aspiration is indicated by the presence of solids, thick fluid, or clear fluids \>1.5ml/kg in the gastric antrum in the right lateral decubitus position

Number of subjects that are at low risk for aspiration

时间窗: end of ultrasound

Low risk for aspiration is indicated by a collapsed gastric antrum or clear fluids \<1.5ml/kg in the gastric antrum in the right lateral decubitus position.

次要结局

  • Age(end of ultrasound)
  • Number of participants with Gastroesophageal reflux disease (GERD)(end of ultrasound)
  • Body mass Index (BMI)(end of ultrasound)
  • Physical status as assessed by the American Society of Anesthesiologists (ASA) physical status classification system(end of ultrasound)
  • Number of participants with reported nothing by mouth (NPO) status(end of ultrasound)
  • Number of participants that have use opioids preoperatively(end of ultrasound)
  • Number of participants with diabetes(end of ultrasound)
  • Number of participants that are male as indicated in the medical records(end of ultrasound)
  • Number of participants that are female as indicated in the medical records(end of ultrasound)
  • Pain severity as assessed by the numeric scale(end of ultrasound)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sudipta Sen

Assisstant Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验